Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000235095

Medchemexpress LLC Dasminapant | 1570231-89-8 | 99.7% | 1157.40 | C60H72N10O10S2 | 1MG
SDP

Catalog No. 5000235095
Encompass_Preferred

Dasminapant (APG-1387) is a bivalent SMAC mimetic and inhibitor of apoptosis protein (IAP) antagonist provided for research use. It promotes degradation of cIAP-1 and XIAP, activates caspase-3, and induces apoptosis in preclinical cancer models, supporting studies in hepatocellular, ovarian, and nasopharyngeal carcinoma.

  • Bivalent SMAC mimetic that antagonizes IAP family proteins.
  • Promotes degradation of cIAP-1 and XIAP and triggers caspase activation.
  • Used in preclinical studies of various solid tumors.
  • High reported purity suitable for research applications.
  • Available in small milligram pack sizes for experimental use.

Catalog No. 50-002-35095 Supplier Medchemexpress LLC Supplier No. HY1255931MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Dasminapant (APG-1387) is a bivalent SMAC mimetic and inhibitor of apoptosis protein (IAP) antagonist provided for research use. It promotes degradation of cIAP-1 and XIAP, activates caspase-3, and induces apoptosis in preclinical cancer models, supporting studies in hepatocellular, ovarian, and nasopharyngeal carcinoma.

  • Bivalent SMAC mimetic that antagonizes IAP family proteins.
  • Promotes degradation of cIAP-1 and XIAP and triggers caspase activation.
  • Used in preclinical studies of various solid tumors.
  • High reported purity suitable for research applications.
  • Available in small milligram pack sizes for experimental use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.